Henry Schein Inc (HSIC):企業の財務・戦略的SWOT分析

◆英語タイトル:Henry Schein Inc (HSIC) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1604
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:57
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Henry Schein Inc (HSIC) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Henry Schein Inc (Henry Schein) is a provider of health care products and services to dental and medical practitioners. Its product portfolio consists of infection-control products, preventatives, composites, anesthetics, dental implants, generic and branded drugs, vaccines, surgical products and diagnostic tests, among others. It also offers technology solutions such as practice management software; and e-commerce solutions, equipment repair, financial services and other value-added services. The company serves dental practitioners, laboratories and physician practices, government, institutional health care clinics and other alternate care clinics across the world. It operates in Germany, Canada, France, Switzerland, the UK and the US, among others. Henry Schein is headquartered in New York, the US.

Henry Schein Inc Key Recent Developments

Apr 04,2020 Department of Justice issues business review letter to medical supplies distributors supporting project Airbridge under expedited procedure for covid-19 pandemic response
Mar 16,2020 Henry Schein launches COVID-19 resource center
Mar 10,2020 Henry Schein forms Joint Venture with Casa Schmidt to serve dental professionals in Spain and Portugal
Feb 25,2020 Henry Schein Named One of the 2020 World’s Most Ethical Companies by Ethisphere

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Henry Schein Inc – Key Facts
Henry Schein Inc – Key Employees
Henry Schein Inc – Key Employee Biographies
Henry Schein Inc – Major Products and Services
Henry Schein Inc – History
Henry Schein Inc – Company Statement
Henry Schein Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Henry Schein Inc – Business Description
Business Segment: Health Care Distribution
Overview
Performance
Key Stats
Business Segment: Technology and Value-Added Services
Overview
Performance
Key Stats
Geographical Segment: Other Countries
Target Markets
Performance
Geographical Segment: United States
Performance
Henry Schein Inc – Corporate Strategy
Henry Schein Inc – SWOT Analysis
SWOT Analysis – Overview
Henry Schein Inc – Strengths
Henry Schein Inc – Weaknesses
Henry Schein Inc – Opportunities
Henry Schein Inc – Threats
Henry Schein Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Henry Schein Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Henry Schein Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Henry Schein Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 04, 2020: Department of Justice issues business review letter to medical supplies distributors supporting project Airbridge under expedited procedure for covid-19 pandemic response
Mar 16, 2020: Henry Schein launches COVID-19 resource center
Mar 10, 2020: Henry Schein forms Joint Venture with Casa Schmidt to serve dental professionals in Spain and Portugal
Feb 25, 2020: Henry Schein Named One of the 2020 World’s Most Ethical Companies by Ethisphere
Feb 20, 2020: Henry Schein reports record fourth quarter 2019 financial results from continuing operations
Feb 11, 2020: Henry Schein’s Steven W. Kess named President of the Santa Fe Group
Jan 30, 2020: HR for Health and Henry Schein announce exclusive business relationship to provide doctors with new solutions to simplify human resources & payroll
Jan 29, 2020: UPS and Henry Schein sign agreement to explore Drone Delivery
Jan 13, 2020: Henry Schein opens disaster relief fund to aid relief efforts in response to Australian bushfires
Dec 04, 2019: Henry Schein and the National Council on disability ally to improve access to care for Americans with disabilities
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Henry Schein Inc, Key Facts
Henry Schein Inc, Key Employees
Henry Schein Inc, Key Employee Biographies
Henry Schein Inc, Major Products and Services
Henry Schein Inc, History
Henry Schein Inc, Subsidiaries
Henry Schein Inc, Key Competitors
Henry Schein Inc, Ratios based on current share price
Henry Schein Inc, Annual Ratios
Henry Schein Inc, Annual Ratios (Cont...1)
Henry Schein Inc, Annual Ratios (Cont...2)
Henry Schein Inc, Interim Ratios
Henry Schein Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Henry Schein Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
Henry Schein Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Henry Schein Inc, Performance Chart (2015 - 2019)
Henry Schein Inc, Ratio Charts
Henry Schein Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
Henry Schein Inc, Medical Equipment, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Henry Schein Inc (HSIC):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Petrofac Ltd (PFC):企業の財務・戦略的SWOT分析
    Petrofac Ltd (PFC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Cadogan Petroleum Plc (CAD):石油・ガス:M&Aディール及び事業提携情報
    Summary Cadogan Petroleum Plc (Cadogan) is an independent upstream energy company that carries out exploration, development and production of oil and gas. It also conducts gas trading operations, which include the import of gas from European countries, and purchase and sale in the domestic market. T …
  • Celgene Corp (CELG):企業の財務・戦略的SWOT分析
    Celgene Corp (CELG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Saneca Pharmaceuticals as:製薬・医療:M&Aディール及び事業提携情報
    Summary Saneca Pharmaceuticals as (Saneca Pharma) is a contract development and manufacturing organization that develops and manufactures active pharmaceutical ingredients and finished dosage forms. The organization provides products such as API's; 2-aminotridecane adipate, atorvastatin calcium crys …
  • Thetis Pharmaceuticals LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Thetis Pharmaceuticals LLC (Thetis Pharma) is a drug manufacturing company that offers novel immuno-resolving therapies. The company develops and manufactures drugs for type two diabetes and chronic conditions. Its pipeline products include TP252, TP6211, TP113, and TP 101. Thetis Pharma’s T …
  • Arno Therapeutics Inc (ARNI)-医療機器分野:企業M&A・提携分析
    Summary Arno Therapeutics Inc (Arno) is a clinical stage biopharmaceutical company that develops products for the treatment of cancer, infectious diseases and other life threatening diseases. The company has exclusive worldwide rights for the development and commercialization of Onapristone (for the …
  • Lietuvos Draudimas AB:企業の戦略的SWOT分析
    Lietuvos Draudimas AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • BBMG Corporation:企業の戦略・SWOT・財務情報
    BBMG Corporation - Strategy, SWOT and Corporate Finance Report Summary BBMG Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Fuji Oil Co Ltd (5017):企業の財務・戦略的SWOT分析
    Fuji Oil Co Ltd (5017) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • GETECH Group plc (GTC):企業の財務・戦略的SWOT分析
    Summary Getech Group Plc (Getech) is an oil and gas service company that offers geological and geophysical services. The company’s services include regional reports, globe, commissions and global gravity and magnetic data solutions. Its in-house specialties comprise airborne geophysics, potential fi …
  • Fresenius SE & Co KGaA (FRE):医療機器:M&Aディール及び事業提携情報
    Summary Fresenius SE & Co KGaA (Fresenius) is a global health care group, which offers products and services for dialysis treatment. It provides various dialysis services through its own clinics and sells its products to other dialysis service providers. Its major products and services includes mach …
  • Artes Biotechnology GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Artes Biotechnology GmbH (ARTES) is a developer of recombinant production cell lines and processes that is based on the microbial expression platforms. The company offers biosimilars, enzymes and proteins and vaccines. It offers technology transfer and implementation support, protein analyti …
  • Vitol Group:企業の戦略・SWOT・財務情報
    Vitol Group - Strategy, SWOT and Corporate Finance Report Summary Vitol Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • InMed Pharmaceuticals Inc (IN)-製薬・医療分野:企業M&A・提携分析
    Summary InMed Pharmaceuticals Inc (InMed), formerly Cannabis Technologies Inc, is a pre-clinical stage biopharmaceutical company which develops, produces and markets plant cannabinoid based pharmaceutical products to related healthcare markets. The company's pipeline products include INM-750 and INM …
  • PTC Therapeutics Inc (PTCT):製薬・医療:M&Aディール及び事業提携情報
    Summary PTC Therapeutics Inc (PTC Therapeutics) discovers, develops, and commercializes orally active small molecule therapeutics that target post transcriptional control. The company's pipeline products include an orally administered small-molecule targeted at genetic disorders due to a nonsense mu …
  • Drugs for Neglected Diseases initiative:製薬・医療:M&Aディール及び事業提携情報
    Summary Drugs for Neglected Diseases initiative (DNDi) is a non-profit drug research and development (R&D) organization which discovers and develops new drugs for neglected diseases. The organization develops therapeutics for the treatment of various diseases such as human African trypanosomiasis (H …
  • Applied Genetic Technologies Corp (AGTC)-製薬・医療分野:企業M&A・提携分析
    Summary Applied Genetic Technologies Corp (AGTC) is a pharmaceutical company that offers development of eye disease cures. The company develops treatments for patients that have diseases caused by broken genes. It provides products such as x-linked retinoschisis, achromatopsia, x-linked retinitis pi …
  • Chicago Bridge & Iron Company NV (CBI):電力:M&Aディール及び事業提携情報
    Summary Chicago Bridge & Iron Company NV (CB&I) is a provider of technology and infrastructure solutions. Its services include conceptual design, technology, engineering, procurement, modularization, construction, fabrication, commissioning, maintenance, program management and environmental services …
  • Town Centre Securities Plc:企業の戦略・SWOT・財務情報
    Town Centre Securities Plc - Strategy, SWOT and Corporate Finance Report Summary Town Centre Securities Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Nordic Bioscience AS:製薬・医療:M&Aディール及び事業提携情報
    Summary Nordic Bioscience AS (Nordic Bioscience), formerly Danish Biotech Co is a preclinical and clinical drug development company that offers serological biochemical solutions. The company offers diagnostic products, laboratory kits and biochemical assays. It provides degradation biomarkers, forma …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆